MENU

NEO Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys NEO on November 19, 2025, netting in a 16.10% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+16.10% Gain from a Successful pattern Three Rising Valleys
NEO - NeoGenomics
Tickeron
Ticker: NEO
Company: NeoGenomics
Gain: +16.1%
Confirmed: 11/19/25
Succeeded: 11/24/25
Total length: 12 days

On November 12, 2025, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for NeoGenomics (NEO, $10.00). On November 19, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $12.38. 5 days later, on November 24, 2025, NEO reached the target price resulting in a +1 for traders who took a long position in the stock.

NEO in -1.94% downward trend, declining for three consecutive days on November 28, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NEO declined for three days, in of 313 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

NEO broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on NEO as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NEO just turned positive on November 21, 2025. Looking at past instances where NEO's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for NEO moved above the 200-day moving average on November 04, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 169 cases where NEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.871) is normal, around the industry mean (12.782). P/E Ratio (0.000) is within average values for comparable stocks, (138.244). NEO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.932). NEO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.183) is also within normal values, averaging (11.043).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
NEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NEO showed earnings on October 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of genetic and molecular testing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
9490 NeoGenomics Way
Phone
+1 239 768-0600
Employees
2100
Web
https://www.neogenomics.com